Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy.
James B DoubVincent Y NgEleanor WilsonLorenzo CorsiniBenjamin K ChanPublished in: Pharmaceuticals (Basel, Switzerland) (2021)
Here, we present a case of a 79-year-old female with a recalcitrant Staphylococcal epidermidis prosthetic knee infection that was successfully treated with a single dose of adjuvant intra-articular bacteriophage therapy after debridement and implant retention surgery. The bacteriophage used in this case, PM448, is the first ɛ2 bacteriophage to be used in vivo. Currently the patient is without evidence of clinical recurrence and, interestingly, the patient had also suffered from debilitating aplastic anemia for over 2 years, which is recovering since receiving adjuvant bacteriophage therapy.
Keyphrases
- staphylococcus aureus
- biofilm formation
- total knee arthroplasty
- early stage
- case report
- minimally invasive
- patients undergoing
- stem cells
- pseudomonas aeruginosa
- escherichia coli
- coronary artery bypass
- acute coronary syndrome
- heavy metals
- atrial fibrillation
- bone marrow
- acute lymphoblastic leukemia
- polycyclic aromatic hydrocarbons
- water soluble